Citations

Showing 10 of 108104 citations.

The Therapeutic Potential of Exosomes in Soft Tissue Repair and Regeneration
Wan, Rou , Moran, Steven L. , Zhao, Chunfeng , Hussain, Arif , Behfar, Atta

Mayo Clinic

International Journal of Molecular Sciences | March 31, 2022 | Volume: 23 | Issue: 7 | Pages: 3869

10.3390/ijms23073869 | PMID 35409228 Get It

Soft tissue defects are common following trauma and tumor extirpation. These injuries can result in poor functional recovery and lead to a diminished quality of life. The healing of skin and muscle is a complex process that, at present, leads to incomplete recovery and scarring. Regenerative medicine may offer the opportunity to improve the healing process and functional outcomes. Barriers to regenerative strategies have included cost, regulatory hurdles, and the need for cell-based therapies. In recent years, exosomes, or extracellular vesicles, have gained tremendous attention in the field of soft tissue repair and regeneration. These nanosized extracellular particles (30–140 nm) can break the cellular boundaries, as well as facilitate intracellular signal delivery in various regenerative physiologic and pathologic processes. Existing studies have established the potential of exosomes in regenerating tendons, skeletal muscles, and peripheral nerves through different mechanisms, including promoting myogenesis, increasing tenocyte differentiation and enhancing neurite outgrowth, and the proliferation of Schwann cells. These exosomes can be stored for immediate use in the operating room, and can be produced cost efficiently. In this article, we critically review the current advances of exosomes in soft tissue (tendons, skeletal muscles, and peripheral nerves) healing. Additionally, new directions for clinical applications in the future will be discussed.
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics
König, Frederik , Grossmann, Nico C. , D’Andrea, David , Juvet, Tristan , Potretzke, Aaron M. , Djaladat, Hooman , Ghoreifi, Alireza , Kikuchi, Eiji , Hayakawa, Nozomi , Mari, Andrea , Khene, Z. , Fujita, Kazutoshi , Fontana, Matteo , Sfakianos, John P. , Pfail, John , Laukhtina, Ekaterina , Rajwa, Paweł , Pallauf, Maximilian , Cacciamani, Giovanni , Doeveren, Thomas van , Boormans, Joost L., Antonelli, Alessandro , Jamil, Marcus , Budzyn, Jeffrey, Ploussard, Guillaume , Heidenreich, Axel , Daneshmand, Siamak , Boorjian, Stephen A. , Rink, Michael , Shariat, Shahrokh F. , Pradère, Benjamin , D'Andrea, David , Juvet, Tristan , Potretzke, Aaron, Ghoreifi, Alireza , Kikuchi, Eiji , Mari, Andrea , Khene, Zine-Eddine , Fujita, Kazutoshi , Fontana, Matteo , Laukhtina, Ekaterina , Pallauf, Maximilian , Cacciamani, Giovanni E , van Doeveren, Thomas , Boormans, Joost L , Antonelli, Alessandro , Ploussard, Guillaume , Daneshmand, Siamak , Shariat, Shahrokh F , Pradere, Benjamin , Grossman, Nico C , Rajwa, Pawel , Soria, Francesco , Raman, Jay D. , Breda, Alberto , Abdollah, Firas , Rouprêt, Morgan

Mayo Clinic

Cancers | March 31, 2022 | Volume: 14 | Issue: 7 | Pages: 1781

10.3390/cancers14071781 | PMID 35406553 Get It

Background: Measuring quality of care indicators is important for clinicians and decision making in health care to improve patient outcomes. Objective: The primary objective was to identify quality of care indicators for patients with upper tract urothelial carcinoma (UTUC) and to validate these in an international cohort treated with radical nephroureterectomy (RNU). The secondary objective was to assess the factors associated with failure to validate the pentafecta. Design: We performed a retrospective multicenter study of patients treated with RNU for EAU high-risk (HR) UTUC. Outcome measurements and statistical analysis: Five quality indicators were consensually approved, including a negative surgical margin, a complete bladder-cuff resection, the absence of hematological complications, the absence of major complications, and the absence of a 12-month postoperative recurrence. After multiple imputations and propensity-score matching, log-rank tests and a Cox regression were used to assess the survival outcomes. Logistic regression analyses assessed predictors for pentafecta failure. Results: Among the 1718 included patients, 844 (49%) achieved the pentafecta. The median follow-up was 31 months. Patients who achieved the pentafecta had superior 5-year overall- (OS) and cancer-specific survival (CSS) compared to those who did not (68.7 vs. 50.1% and 79.8 vs. 62.7%, respectively, all p < 0.001). On multivariable analyses, achieving the pentafecta was associated with improved recurrence-free survival (RFS), CSS, and OS. No preoperative clinical factors predicted a failure to validate the pentafecta. Conclusions: Establishing quality indicators for UTUC may help define prognosis and improve patient care. We propose a pentafecta quality criteria in RNU patients. Approximately half of the patients evaluated herein reached this endpoint, which in turn was independently associated with survival outcomes. Extended validation is needed.
Travel-Associated Venous Thromboembolism
Johnson, Isla McKerrow , Shatzel, Joseph J. , Olson, Sven R. , Kohl, Tovah , Hamilton, Andrew , McKerrow Johnson, Isla, Johnson, Isla , DeLoughery, Thomas G.

Mayo Clinic

Wilderness & Environmental Medicine | March 31, 2022 | Volume: 33 | Issue: 2 | Pages: 169-178

10.1016/j.wem.2022.02.004 | PMID 35370084 Get It

Introduction Long-distance travel is assumed to be a risk factor for venous thromboembolism (VTE). However, the available data have not clearly demonstrated the strength of this relationship, nor have they shown evidence for the role of thromboprophylaxis. Methods We performed a systematic review of the literature. We also summarized available guidelines from 5 groups. Results We found 18 studies that addressed this question. Based on the data presented in the review, we conclude that there is an association between VTE and length of travel, but this association is mild to moderate in effect size with odds ratios between 1.1 and 4. A dose-response relationship between VTE and travel time was identified, with a 26% higher risk for every 2 h of air travel ( P=0.005) starting after 4 h. The quality of evidence for both travel length and thromboprophylaxis was low. However, low-risk prophylactic measures such as graduated compression stockings were shown to be effective in VTE prevention. There is heterogeneity among the different practice guidelines. The guidelines generally concur that no prophylaxis is necessary in travelers without known thrombosis risk factors and advocate for conservative treatment such as compression stockings over pharmacologic prophylaxis. Conclusions We conclude air travel is a risk factor for VTE and that there is a dose relationship starting at 4 h. For patients with risk factors, graduated compression stockings are effective prophylaxis.
Reverberation clutter signal suppression in ultrasound attenuation estimation using wavelet-based robust principal component analysis
Lok, U‐Wai , Huang, Chengwu , Tang, Shanshan , Zhou, Chenyun , Watt, Kymberly D., Callstrom, Matthew R. , Trzasko, Joshua D. , Chen, Shigao , Gong, Ping , Huang, Chengwu , Yang, Lulu, Callstrom, Matthew, Lok, U-Wai , Gong, Ping , Yang, Lulu

Mayo Clinic

Physics in Medicine & Biology | March 31, 2022 | Volume: 67 | Issue: 9 | Pages: 095018

10.1088/1361-6560/ac62fd | PMID 35358950 Get It

Abstract Objective . Ultrasound attenuation coefficient estimation (ACE) has diagnostic potential for clinical applications such as quantifying fat content in the liver. Previously, we have proposed a system-independent ACE technique based on spectral normalization of different frequencies, called the reference frequency method (RFM). This technique does not require a well-calibrated reference phantom for normalization. However, this method may be vulnerable to severe reverberation clutter introduced by the body wall. The clutter superimposed on liver echoes may bias the estimation. Approach . We proposed to use robust principal component analysis, combined with wavelet-based sparsity promotion, to suppress the severe reverberation clutters. The capability to mitigate the reverberation clutters was validated through phantom and in vivo studies. Main Results . In the phantom studies with added reverberation clutters, higher normalized cross-correlation and smaller mean absolute errors were attained as compared to RFM results without the proposed method, demonstrating the capability to reconstruct tissue signals from reverberations. In a pilot patient study, the correlation between ACE and proton density fat fraction (PDFF), a measurement of liver fat by MRI as a reference standard, was investigated. The proposed method showed an improvement of the correlation (coefficient of determination, R = 0.82) as compared with the counterpart without the proposed method ( R = 0.69). Significance : The proposed method showed the feasibility of suppressing the reverberation clutters, providing an important basis for the development of a robust ACE with large reverberation clutters.
Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors
Koubek, Emily J. , Ralya, Andrew T., Larson, Thomas R. , McGovern, Renee M., Buhrow, Sarah A. , Covey, Joseph M. , Adjei, Alex A. , Takebe, Naoko , Ames, Matthew M. , Reid, Joel M. , Goetz, Matthew P.

Mayo Clinic

The Journal of Clinical Pharmacology | March 31, 2022 | Volume: 62 | Issue: 9 | Pages: 1121-1131

10.1002/jcph.2053 | PMID 35358345 Get It

AbstractThe purpose of this study was to develop and validate a population pharmacokinetic model for Z‐endoxifen in patients with advanced solid tumors and to identify clinical variables that influence pharmacokinetic parameters. Z‐endoxifen‐HCl was administered orally once a day on a 28‐day cycle (±3 days) over 11 dose levels ranging from 20 to 360 mg. A total of 1256 Z‐endoxifen plasma concentration samples from 80 patients were analyzed using nonlinear mixed‐effects modeling to develop a population pharmacokinetic model for Z‐endoxifen. A 2‐compartment model with oral depot and linear elimination adequately described the data. The estimated apparent total clearance, apparent central volume of distribution, and apparent peripheral volume of distribution were 4.89 L/h, 323 L, and 39.7 L, respectively, with weight‐effect exponents of 0.75, 1, and 1, respectively. This model was used to explore the effects of clinical and demographic variables on Z‐endoxifen pharmacokinetics. Weight, race on clearance, and aspartate aminotransferase on the absorption rate constant were identified as significant covariates in the final model. This novel population pharmacokinetic model provides insight regarding factors that may affect the pharmacokinetics of Z‐endoxifen and may assist in the design of future clinical trials.
WITHDRAWN: Outcomes of Endoscopic Resection for Colorectal Polyps with High Grade Dysplasia or Intramucosal Cancer
Mohapatra, Sonmoon , Almazan, Erik , Recinos, Luisa, Bassi, Mehak, Broder, Arkady, Salimian, Kevan J. , Khashab, Mouen A., Ngamruengphong, Saowanee , Charilaou, Paris , Khashab, Mouen A.

Mayo Clinic

No container title available | March 31, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1493444/v1 Get It

Abstract Purpose: Little is known about the outcomes of endoscopic resection (ER) for patients with colorectal adenomas (CRAs) with high-grade dysplasia (HGD) or intramucosal cancer (IMCA). This study aimed to estimate the rate of local/malignant recurrence, identify the predictive factors for local recurrence (LR) and evaluate the treatment outcomes of recurrence after ER for HGD/IMCA. Methods: A retrospective review was performed to identify patients who underwent ER for HGD/IMCA in two academic medical centers. Risk factors for LR were determined by Cox regression analysis. Results: Overall, 188 lesions with HGD/IMCA were included; 61 lesions were removed by en-bloc ER (e-ER), whereas 127 lesions were removed in a piecemeal ER (p-ER). The mean lesion size was 20.3 mm. Of the 125 patients who underwent follow-up, local adenoma recurrence occurred in 31 (23%), and malignant recurrence occurred in 2 (1.6%) patients at a median follow-up of 8 months. HGD/IMCA ≥ 4 cm removed by p-ER have the greatest hazard ratio (HR=21.5, 95% CI: 2.5-180.5; p=0.005) for LR, compared to the HGD/IMCA < 4 cm removed by e-ER. Surgery was performed in 3.2% of patients after a complete ER, all after p-ER. Of all patients who had LR, 22.6% (7/31 patients) had recurrent/residual adenomas despite repeat ER attempts after a mean of 1.9±0.79 procedures from the index ER. Conclusions: Our study demonstrates high rate of LR (23%) after ER of CRAs with HGD/IMCA with rate of malignant recurrence of 1.6% especially after p-ER. Thus, e-ER should be preferred for these lesions whenever technically feasible.
Patellar Tendinopathy: Critical Analysis Review of Current Nonoperative Treatments
Marigi, Erick M. , Buckley, Patrick J. , Razi, Farzad , Abbas, Muhammad J. , Jildeh, Toufic R. , Camp, Christopher L. , Krych, Aaron J. , Okoroha, Kelechi R. , Camp, Christopher L. , Krych, Aaron J , Marigi, Erick , Buckley, Patrick

Mayo Clinic

JBJS Reviews | March 31, 2022 | Volume: 10 | Issue: 3 | Pages: No page available

10.2106/jbjs.rvw.21.00168 | PMID 35358114 Get It

» Patellar tendinopathy is an attritional injury of the patellar tendon that is frequently identified in jumping athletes. Through repetitive or explosive movements, considerable loads and high peak strains are generated across the patellar tendon. » This leads to microinjury of tendon fibers, local mucoid degeneration, and loss of the fibrocartilaginous tissue that attaches tendon to bone. » Management of patellar tendinopathy often begins with nonoperative modalities: progressive tendon loading and eccentric rehabilitative exercise programs are the most effective. While a variety of additional treatment modalities are available, the comparative efficacy of these supportive treatments is not well differentiated at this time. » In this article, we analyze the existing literature regarding nonoperative treatment of patellar tendinopathy and provide additional insight on the effectiveness of current modalities.
Clinical and ultrasound biomicroscopic (UBM) correlation in eyes with closed globe injury
Ganekal, Sunil , Dorairaj, Syril , Ganekal, Varun

Mayo Clinic

Indian Journal of Clinical and Experimental Ophthalmology | March 31, 2022 | Volume: 8 | Issue: 1 | Pages: 55-60

10.18231/j.ijceo.2022.011 Get It

To correlate UBM and clinical findings in patients with closed globe injury. Prospective observational study of 75 patients, ≥ 12 years of age presenting to ophthalmic outpatient department within one week of sustaining closed globe injury. Patients with seriously ill polytrauma and open globe injuries were excluded from the study. Comprehensive ophthalmic examination including Visual acuity assessment, slit lamp examination, fundus examination and IOP measurement. Gonioscopy and UBM examination was done in all patients on presentation except for patients with hyphema (UBM and gonioscopy done at 4 weeks to prevent rebleed).Mean age of the patients was 31.4 ±8 years, most common external findings included lid ecchymosis (47%), subconjunctival hemorrhage (93%). The common anterior segment finding included traumatic iritis (87%), traumatic hyphema (61%) and traumatic cataract in 27% of patients. Clinical evidence of zonular dialysis was seen in 13% of patients. UBM was able to detect zonular defects in 62% patients (P=0.008). Most of the patients (57%) had zonular dialysis less than 3 clock hours on UBM examination. UBM confirmed the presence of other clinical findings like iridodialysis, cyclodialysis. UBM is a safe and effective adjunctive tool for clinical assessment and management of ocular trauma. It can diagnose subtle zonular dialysis and other anterior segment changes following blunt trauma. UBM should be an integral part of ophthalmic examination especially in patients requiring surgical intervention after closed globe injury.
HSR22-137: Proton Radiotherapy Utilization for Patients Diagnosed in 2018: A National Cancer Database Analysis
Malouff, Timothy D. , Waddle, Mark R. , Foote, Robert L. , Ebner, Daniel

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 31, 2022 | Volume: 20 | Issue: 3.5 | Pages: HSR22-137

10.6004/jnccn.2021.7311 Get It